(PharmaNewsWire.Com, September 29, 2017 ) The use of medical plastic, stainless steel /titanium metal replacement implant materials for medical purposes, is being effected by biocompatibility issues, in addition to demand for superior implant mechanical performance. For this, the manufactures are looking towards more effective and companionable materials.
Increased use of biomaterials is mainly attributed to the research efforts in medical technology for the efficient functionality of medical implants. In addition, increase in government funding’s, and availability of new technologies such as hydrogen scaffolding and decellularized dermal matrixes for grafting are some of the factors driving the growth for Middle-East & Africa biomaterials market. And also due to the increasing number of geriatric patients, the demand for usage of biomaterials in cardiology, wound healing, neurology and plastic surgery is also on a rise. Besides, will contribute to the market in growing at a healthy rate throughout the forecast period.
However, adverse reaction to biomaterial implants, inflammation and fracture issues, high cost associated with and difficulties in manufacturing are the major factors off-putting the growth for Middle-East & Africa biomaterials market.
Based on the types of material, the Middle-East & Africa biomaterials market is categorized into ceramic, metallic, polymers, and natural biomaterials. Polymers will have the fastest growth rate in the coming years owing to its distinct material properties such as bio- inertness, flexibility, longevity, biocompatibility and durability. The persistent demand from geriatrics and rising incidence of ophthalmic disorders leads to frequent usage of polymers for ophthalmological purposes.
Further, based on application, the market is segmented into orthopaedic, dental, cardiovascular, plastic surgery, ophthalmology, wound healing, tissue engineering, neurological /central nervous systems, and other applications which include drug delivery systems, bariatric surgery, gastrointestinal and urinary applications.Moreover, on the basis of geography, the Middle-East & Africa Market is segmented and analysed under regions of Middle-East and Africa.
While existing players operating in the Middle-East & Africa are trying to expand their product portfolio and increase growth, few companies are trying to enter the market through acquisitions to capitalize on the growing opportunities. Some of the key players in the Middle-East & Africa biomaterials market include Royal DSM, Zimmer Biomet Holdings, Inc., Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Evonik Industries AG, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
